Theravance Biopharma (TBPH) Non-Current Deffered Revenue (2013 - 2023)
Theravance Biopharma (TBPH) recorded Non-Current Deffered Revenue of $175,000 in Q3 2023, down 12.1% from $199,000 a year earlier and down 3.3% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Non-Current Deffered Revenue (2013 - 2023) Analysis & Trends
At the end of FY2022, Theravance Biopharma reported Non-Current Deffered Revenue of $192,000, down 38.1% from FY2021.
- Annual Non-Current Deffered Revenue has declined for four straight years, with a five-year compound annual growth rate of -33.1% (FY2017 to FY2022).
- Across earlier years, Non-Current Deffered Revenue came in at $310,000 in FY2021 (-10.9%), $348,000 in FY2020 (-94.9%), $6.76 million in FY2019 (-74.2%) and $26.18 million in FY2018.
- The Q3 2023 figure is the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2013.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for 19 consecutive quarters, with an average decline of 24.7% over the last eight quarters.
- Across the past five years, year-over-year decline in Non-Current Deffered Revenue ran from 10.9% in Q4 2021 to 96.0% in Q1 2021.
- Per Business Quant, the preceding three quarters came in at $181,000 (Q2 2023), $187,000 (Q1 2023) and $192,000 (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 175,000.00 |
| Jun 30, 2023 | 181,000.00 |
| Mar 31, 2023 | 187,000.00 |
| Dec 31, 2022 | 192,000.00 |
| Sep 30, 2022 | 199,000.00 |
| Jun 30, 2022 | 204,000.00 |
| Mar 31, 2022 | 301,000.00 |
| Dec 31, 2021 | 310,000.00 |
| Sep 30, 2021 | 320,000.00 |
| Jun 30, 2021 | 329,000.00 |
| Mar 31, 2021 | 339,000.00 |
| Dec 31, 2020 | 348,000.00 |
| Sep 30, 2020 | 750,000.00 |
| Jun 30, 2020 | 1.15 Mn |
| Mar 31, 2020 | 8.51 Mn |
| Dec 31, 2019 | 6.76 Mn |
| Sep 30, 2019 | 14.17 Mn |
| Jun 30, 2019 | 13.44 Mn |
| Mar 31, 2019 | 21.73 Mn |
| Dec 31, 2018 | 26.18 Mn |
API Access
Theravance Biopharma Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();